© Praxhub 2023, all rights reserved.
Continuing Medical Education (CME) plays a crucial role in the continuous professional development of healthcare practitioners. These educational programs provide professionals with the latest medical knowledge, evidence-based practices, and skills to enhance patient care.
While the primary goal of CME is to improve patient outcomes and healthcare quality, it is undeniable that well-structured and unbiased CME education can also lead to increased drug sales in the healthcare industry. A study conducted in the U.S. found that the pharmaceutical industry – the largest financial contributor to the development of CME programs – believes that it will recoup US$3.56 in new drug sales for every dollar spent on CME.¹
In this article, we explore the reasons why CME education can positively influence therapeutic sales.
Blog / Can CME really drive new product sales?
CME education emphasises adherence to industry guidelines, product indications, regulations, and ethical standards. Healthcare professionals must comply with these regulations when prescribing or recommending the use of medical products. CME helps ensure that practitioners are aware of the latest compliance and indication requirements, which can influence their prescribing behaviours. Companies that produce compliant and well-regulated products may experience increased sales as a result.
Informed and well-educated healthcare professionals inspire trust and confidence among their patients. Patients are more likely to accept treatment recommendations and prescriptions when they know that their healthcare provider is up-to-date with the latest advancements in medical knowledge. This trust can lead to greater patient compliance and adherence to prescribed treatments, potentially resulting in increased product demand.
CME courses emphasise evidence-based medicine, where healthcare decisions are rooted in rigorous scientific research and clinical trials. When healthcare professionals are exposed to compelling evidence supporting the efficacy and safety of a particular product, they are more likely to integrate it into their practice. Consequently, increased adoption of evidence-based products can drive up sales for those products.
CME programs often include updates on new medical products, pharmaceuticals, and medical devices. By participating in these educational activities, healthcare professionals gain in-depth knowledge about the features, benefits, and clinical applications of various products. The increased awareness and familiarity with a product can lead to higher confidence levels when using and recommending it to patients, ultimately resulting in an increase in product sales.
Continuing Medical Education (CME) is a cornerstone of maintaining high standards of healthcare practice. While its primary objective is to enhance patient care and outcomes, it is evident that CME education can also lead to increased product sales in the healthcare industry. By providing healthcare professionals with the latest knowledge, evidence-based practices, and networking opportunities, CME ensures that practitioners are well-informed about the most effective and appropriate medical products for their patients.
However, it is crucial to maintain the integrity and objectivity of CME education to avoid any undue influence on product recommendations and sales. The ultimate goal should always be to improve patient care and safety while fostering a well-informed and skilled healthcare workforce.
So, is your organisation keeping up with the evolving landscape of CPD education?
CME activities often attract key opinion leaders (KOLs) in various medical specialties. These influential figures play a vital role in disseminating knowledge and shaping clinical practices within their professional communities. When KOLs are well-educated about a product's benefits and efficacy, they can become advocates and endorse the product, driving further adoption and sales.
CME programs often highlight emerging clinical challenges and unmet needs within the healthcare industry. Pharmaceutical and medical device companies that develop therapeutics and products to address these unmet needs can benefit from CME education. When healthcare professionals recognise the potential value of a product in meeting specific patient needs, they are more likely to incorporate it into their practice, leading to increased demand and sales.
1. Pharmaceutical industry financial support for medical education: benefit, or undue influence? https://pubmed.ncbi.nlm.nih.gov/19723256/